Joanne is a seasoned biotech executive with over 30 years of experience across large pharma and early-stage biotech in the areas of operations, leadership, product development, process development, clinical & commercial manufacturing, and supply chain. Over the course of her career, she has contributed to the licensure and commercialization of numerous medicines across different modalities and therapeutic areas. She has fostered high-performing, empowered individuals and teams and mutually beneficial partnerships with both internal and external stakeholders.
Before Halozyme, Joanne most recently served as the Chief Technical Officer at Abata Therapeutics, a company developing Treg cell therapies for serious autoimmune and inflammatory diseases. Prior to Abata, she served as the Chief Technical Officer at Aerium Therapeutics, Inc. and as the Chief Operating Officer and interim CEO at Boston Pharmaceuticals. Previously, Joanne served as the Executive Vice President of Global Pharmaceutical Development and Operations at Celgene Corporation where she oversaw the company’s Product Development, Global Manufacturing Operations, Supply Chain, Engineering and Quality functions. Joanne also served in leadership positions at other pharmaceutical and biotech companies, including Shire, Abbott Laboratories, Amgen, and Genentech. She has served as a member of the Board of Directors of public biopharmaceutical companies, including Orchard Therapeutics and Astria Therapeutics.
Joanne holds a Ph.D. in Biochemistry and Molecular Biology from Oregon Health and Science University and completed a postdoctoral fellowship in the department of Pharmaceutical Chemistry at the University of California, San Francisco.
